Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS)

With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.92 million shares. The 52-week range on PYXS shows that it touched its highest point at $6.85 and its lowest point at $1.21 during that stretch. It currently has a 1-year price target of $8.67. Beta for the stock currently stands at 1.10.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PYXS was down-trending over the past week, with a drop of -11.11%, but this was down by -25.00% over a month. Three-month performance dropped to -68.59% while six-month performance fell -67.12%. The stock lost -74.68% in the past year, while it has lost -23.08% so far this year. A look at the trailing 12-month EPS for PYXS yields -1.05 with Next year EPS estimates of -1.30. For the next quarter, that number is -0.32. This implies an EPS growth rate of 40.99% for this year and -18.66% for next year. EPS is expected to grow by 12.25% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -118.72%.

Float and Shares Shorts:

At present, 59.45 million PYXS shares are outstanding with a float of 42.26 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PYXS since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.04977 being high and -$1.12325 being low. For PYXS, this leads to a yearly average estimate of -$1.09176. Based on analyst estimates, the high estimate for the next quarter is -$0.29 and the low estimate is -$0.38. The average estimate for the next quarter is thus -$0.34.